165 related articles for article (PubMed ID: 22771027)
1. Does higher starting dose of FSH stimulation with letrozole improve fertility preservation outcomes in women with breast cancer?
Lee S; Oktay K
Fertil Steril; 2012 Oct; 98(4):961-4.e1. PubMed ID: 22771027
[TBL] [Abstract][Full Text] [Related]
2. Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation in breast cancer patients.
Turan V; Bedoschi G; Moy F; Oktay K
Fertil Steril; 2013 Dec; 100(6):1681-5.e1. PubMed ID: 24055050
[TBL] [Abstract][Full Text] [Related]
3. Ovarian Stimulation in Patients With Cancer: Impact of Letrozole and BRCA Mutations on Fertility Preservation Cycle Outcomes.
Turan V; Bedoschi G; Emirdar V; Moy F; Oktay K
Reprod Sci; 2018 Jan; 25(1):26-32. PubMed ID: 28874104
[TBL] [Abstract][Full Text] [Related]
4. Effect of letrozole at 2.5 mg or 5.0 mg/day on ovarian stimulation with gonadotropins in women undergoing intrauterine insemination.
Noriega-Portella L; Noriega-Hoces L; Delgado A; Rubio J; Gonzales-Castañeda C; Gonzales GF
Fertil Steril; 2008 Nov; 90(5):1818-25. PubMed ID: 18083169
[TBL] [Abstract][Full Text] [Related]
5. High FSH dosing is associated with reduced live birth rate in fresh but not subsequent frozen embryo transfers.
Munch EM; Sparks AE; Zimmerman MB; Van Voorhis BJ; Duran EH
Hum Reprod; 2017 Jul; 32(7):1402-1409. PubMed ID: 28472321
[TBL] [Abstract][Full Text] [Related]
6. Fertility Preservation Success Subsequent to Concurrent Aromatase Inhibitor Treatment and Ovarian Stimulation in Women With Breast Cancer.
Oktay K; Turan V; Bedoschi G; Pacheco FS; Moy F
J Clin Oncol; 2015 Aug; 33(22):2424-9. PubMed ID: 26101247
[TBL] [Abstract][Full Text] [Related]
7. Response to ovarian stimulation in patients facing gonadotoxic therapy.
Johnson LN; Dillon KE; Sammel MD; Efymow BL; Mainigi MA; Dokras A; Gracia CR
Reprod Biomed Online; 2013 Apr; 26(4):337-44. PubMed ID: 23415997
[TBL] [Abstract][Full Text] [Related]
8. [Fertility preservation in breast cancer patients by embryo cryopreservation after ovarian stimulation with letrozole and FSH].
Beckmann MW; Findeklee S
Strahlenther Onkol; 2015 Nov; 191(11):895-6. PubMed ID: 26400478
[No Abstract] [Full Text] [Related]
9. Differential impact of controlled ovarian hyperstimulation on live birth rate in fresh versus frozen embryo transfer cycles: a Society for Assisted Reproductive Technology Clinic Outcome System study.
Gerber RS; Fazzari M; Kappy M; Cohen A; Galperin S; Lieman H; Jindal S; Buyuk E
Fertil Steril; 2020 Dec; 114(6):1225-1231. PubMed ID: 33012553
[TBL] [Abstract][Full Text] [Related]
10. Comparison of ovarian stimulation response in patients with breast cancer undergoing ovarian stimulation with letrozole and gonadotropins to patients undergoing ovarian stimulation with gonadotropins alone for elective cryopreservation of oocytes†.
Pereira N; Hancock K; Cordeiro CN; Lekovich JP; Schattman GL; Rosenwaks Z
Gynecol Endocrinol; 2016 Oct; 32(10):823-826. PubMed ID: 27114051
[TBL] [Abstract][Full Text] [Related]
11. Comparison of the efficacy of the aromatase inhibitor letrozole and clomiphene citrate as adjuvants to recombinant follicle-stimulating hormone in controlled ovarian hyperstimulation: a prospective, randomized, blinded clinical trial.
Barroso G; Menocal G; Felix H; Rojas-Ruiz JC; Arslan M; Oehninger S
Fertil Steril; 2006 Nov; 86(5):1428-31. PubMed ID: 16978619
[TBL] [Abstract][Full Text] [Related]
12. Aromatase inhibition reduces gonadotrophin dose required for controlled ovarian stimulation in women with unexplained infertility.
Mitwally MF; Casper RF
Hum Reprod; 2003 Aug; 18(8):1588-97. PubMed ID: 12871867
[TBL] [Abstract][Full Text] [Related]
13. Relative potencies of anastrozole and letrozole to suppress estradiol in breast cancer patients undergoing ovarian stimulation before in vitro fertilization.
Azim AA; Costantini-Ferrando M; Lostritto K; Oktay K
J Clin Endocrinol Metab; 2007 Jun; 92(6):2197-200. PubMed ID: 17356042
[TBL] [Abstract][Full Text] [Related]
14. Progesterone levels in letrozole associated controlled ovarian stimulation for fertility preservation in breast cancer patients.
Goldrat O; Gervy C; Englert Y; Delbaere A; Demeestere I
Hum Reprod; 2015 Sep; 30(9):2184-9. PubMed ID: 26109617
[TBL] [Abstract][Full Text] [Related]
15. Twin delivery after IVF-ET with variable dose letrozole-FSH protocol of lower estradiol in a patient previously treated for breast cancer: a case report.
Zhang CJ; Zhang Y; Hu GZ; Diao H
Eur J Gynaecol Oncol; 2016; 37(2):278-81. PubMed ID: 27172763
[TBL] [Abstract][Full Text] [Related]
16. Conventional ovarian stimulation and single embryo transfer for IVF/ICSI. How many oocytes do we need to maximize cumulative live birth rates after utilization of all fresh and frozen embryos?
Drakopoulos P; Blockeel C; Stoop D; Camus M; de Vos M; Tournaye H; Polyzos NP
Hum Reprod; 2016 Feb; 31(2):370-6. PubMed ID: 26724797
[TBL] [Abstract][Full Text] [Related]
17. Aromatase inhibition improves ovarian response to follicle-stimulating hormone in poor responders.
Mitwally MF; Casper RF
Fertil Steril; 2002 Apr; 77(4):776-80. PubMed ID: 11937133
[TBL] [Abstract][Full Text] [Related]
18. Outcomes of random-start letrozole protocol with PGT-A in women with breast cancer undergoing fertility preservation.
Turan V; Gayete-Lafuente S; Bang H; Oktay KH
J Assist Reprod Genet; 2023 Oct; 40(10):2401-2408. PubMed ID: 37488389
[TBL] [Abstract][Full Text] [Related]
19. The case for aromatase inhibitors use in oncofertility patients. Should aromatase inhibitors be combined with gonadotropin treatment in breast cancer patients undergoing ovarian stimulation for fertility preservation prior to chemotherapy? A debate.
Fatum M; McVeigh E; Child T
Hum Fertil (Camb); 2013 Dec; 16(4):235-40. PubMed ID: 23863119
[TBL] [Abstract][Full Text] [Related]
20. Letrozole reduces estrogen and gonadotropin exposure in women with breast cancer undergoing ovarian stimulation before chemotherapy.
Oktay K; Hourvitz A; Sahin G; Oktem O; Safro B; Cil A; Bang H
J Clin Endocrinol Metab; 2006 Oct; 91(10):3885-90. PubMed ID: 16882752
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
